Robert E. Hoffman - Apr 1, 2025 Form 3 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
Apr 1, 2025
Transactions value $
$0
Form type
3
Date filed
4/2/2025, 04:15 PM
Previous filing
Jan 6, 2025

No securities are beneficially owned.